Warning letter
Tedec-Meiji Fanna, S.A.: warning letter of Apr 24, 2012
FDA warning letter 243054 · Center for Drug Evaluation and Research
Key facts
| Reference number | 243054 |
|---|---|
| Company | Tedec-Meiji Fanna, S.A. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Apr 24, 2012 |
| Posted date | Apr 24, 2012 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 211.192, 211.84(d)(2), 211.160(b) |
| Inspection city | Alcala de Henares |
| Inspection start date | Jul 18, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: